Manu Ohri - 27 Jan 2023 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Chief Financial Officer
Signature
/s/ Manu Ohri
Issuer symbol
GTBP
Transactions as of
27 Jan 2023
Net transactions value
$0
Form type
4
Filing time
01 Feb 2023, 05:02:39 UTC
Previous filing
19 Jul 2022
Next filing
10 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +500,000 $0.000000 500,000 27 Jan 2023 Common Stock 500,000 $0.8370 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant.